Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(o-chlorophenyl)-2-tert-butylaminoethanol
2. Alpha-((tert-butylamino)methyl)-o-chlorobenzyl Alcohol
3. Atenos
4. Brelomax
5. C-78
6. Hn-078
7. Tulobuterol Hydrochloride
1. 41570-61-0
2. 2-(tert-butylamino)-1-(2-chlorophenyl)ethanol
3. Atenos
4. C-78 (free Base)
5. 2-chloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol
6. 591i9su0f7
7. Chlibamol
8. Bremax
9. Nsc-758643
10. Hokunalin (tn)
11. (+/-)-tulobuterol
12. Tulobuterolum
13. 2-chloro-alpha-[[(1,1-dimethylethyl)amino]methyl]benzenemethanol
14. Tulobuterolum [inn-latin]
15. .alpha.-[(tert-butylamino)methyl]-o-chlorobenzyl Alcohol
16. Tulobuterol [inn:ban:jan]
17. Unii-591i9su0f7
18. .alpha.-((tert-butylamino)methyl)-o-chlorobenzyl Alcohol
19. 2-tert-butylamino-1-(2-chlorphenyl)ethanol
20. Atenos (tn)
21. Hn 078
22. Alpha-((tert-butylamino)methyl)-o-chlorobenzyl Alcohol
23. Spectrum_001648
24. Tulobuterol [mi]
25. Spectrum2_001616
26. Spectrum3_001900
27. Spectrum4_000206
28. Spectrum5_001285
29. Tulobuterol [inn]
30. Tulobuterol [jan]
31. Tulobuterol (jp17/inn)
32. Lopac0_001149
33. Bspbio_003440
34. Kbiogr_000811
35. Kbioss_002128
36. Tulobuterol [who-dd]
37. Divk1c_000712
38. Schembl122692
39. Spbio_001651
40. Chembl1159717
41. Dtxsid7048457
42. Chebi:93856
43. Kbio1_000712
44. Kbio2_002128
45. Kbio2_004696
46. Kbio2_007264
47. Kbio3_002943
48. Ninds_000712
49. Hms2090e11
50. Hms3715j21
51. Amy11155
52. Hy-b1810
53. Bdbm50421717
54. Mfcd00867022
55. Akos010122688
56. Ccg-205223
57. Db12248
58. Nsc 758643
59. Sdccgsbi-0051116.p004
60. Idi1_000712
61. Ncgc00016034-02
62. Ncgc00016034-03
63. Ncgc00016034-09
64. Ncgc00162354-01
65. As-10998
66. Sbi-0051116.p003
67. Db-050772
68. Tulobuterol 1000 Microg/ml In Acetonitrile
69. Cs-0013856
70. Vu0244437-2
71. D02151
72. F17342
73. Ab00053692-02
74. Ab00053692_03
75. 2-(tert-butylamino)-1-(2-chlorophenyl)ethanol #
76. 570t610
77. L013403
78. Q909353
79. 2-(tert-butylamino)-1-(2-chlorophenyl)ethan-1-ol
80. Q-201905
81. Sr-01000076165-4
82. Brd-a37441042-003-02-2
83. 2-chloro-.alpha.-[[(1,1-dimethylethyl)amino]methyl]benzenemethanol
84. (rs)-2-tert-butylamino-1 -phenil Ethanol Monohydrochloride; O-chloro-?-[(tert-butylamino)methyl]benzyl Alcohol Hydrochloride; (+/-)-tulobuterol Hydrochloride
85. 1-(2-chlorophenyl)-2-[[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]amino]ethanol
| Molecular Weight | 227.73 g/mol |
|---|---|
| Molecular Formula | C12H18ClNO |
| XLogP3 | 2.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 4 |
| Exact Mass | 227.1076919 g/mol |
| Monoisotopic Mass | 227.1076919 g/mol |
| Topological Polar Surface Area | 32.3 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 191 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Episodic wheeze, Asthma
Adrenergic beta-Agonists
Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
R - Respiratory system
R03 - Drugs for obstructive airway diseases
R03A - Adrenergics, inhalants
R03AC - Selective beta-2-adrenoreceptor agonists
R03AC11 - Tulobuterol
R - Respiratory system
R03 - Drugs for obstructive airway diseases
R03C - Adrenergics for systemic use
R03CC - Selective beta-2-adrenoreceptor agonists
R03CC11 - Tulobuterol
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Regulatory Info :
Registration Country : South Korea
Brand Name : TULOBUTEROL
Dosage Form : Patch
Dosage Strength : 0.5MG
Packaging : 30 pcs/carton
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
Regulatory Info :
Registration Country : South Korea
Brand Name : TULOBUTEROL
Dosage Form : Patch
Dosage Strength : 1MG
Packaging : 30 pcs/carton
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
Regulatory Info :
Registration Country : South Korea
Brand Name : TULOBUTEROL
Dosage Form : Patch
Dosage Strength : 2MG
Packaging : 30 pcs/carton
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Tulobuterol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tulobuterol, including repackagers and relabelers. The FDA regulates Tulobuterol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tulobuterol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tulobuterol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tulobuterol supplier is an individual or a company that provides Tulobuterol active pharmaceutical ingredient (API) or Tulobuterol finished formulations upon request. The Tulobuterol suppliers may include Tulobuterol API manufacturers, exporters, distributors and traders.
click here to find a list of Tulobuterol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tulobuterol DMF (Drug Master File) is a document detailing the whole manufacturing process of Tulobuterol active pharmaceutical ingredient (API) in detail. Different forms of Tulobuterol DMFs exist exist since differing nations have different regulations, such as Tulobuterol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tulobuterol DMF submitted to regulatory agencies in the US is known as a USDMF. Tulobuterol USDMF includes data on Tulobuterol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tulobuterol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tulobuterol suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tulobuterol Drug Master File in Japan (Tulobuterol JDMF) empowers Tulobuterol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tulobuterol JDMF during the approval evaluation for pharmaceutical products. At the time of Tulobuterol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tulobuterol suppliers with JDMF on PharmaCompass.
Tulobuterol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tulobuterol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tulobuterol GMP manufacturer or Tulobuterol GMP API supplier for your needs.
A Tulobuterol CoA (Certificate of Analysis) is a formal document that attests to Tulobuterol's compliance with Tulobuterol specifications and serves as a tool for batch-level quality control.
Tulobuterol CoA mostly includes findings from lab analyses of a specific batch. For each Tulobuterol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tulobuterol may be tested according to a variety of international standards, such as European Pharmacopoeia (Tulobuterol EP), Tulobuterol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tulobuterol USP).
LOOKING FOR A SUPPLIER?
